Boron Neutron Capture Therapy
Sponsors
Kurosaki Hiromasa, Department of Radiation Oncology, Kawasaki Medical School, Beth Israel Deaconess Medical Center, Taipei Veterans General Hospital, Taiwan, Neuboron Bio-SciTech Co., Ltd.
Conditions
FDG-PET Positive Superficial Tumors
FDG-PET Positive TumorsHead and Neck CancerMalignant melanomaMelanoma (Skin)breast cancer
breast cancer
Early Phase 1
Phase 1
Phase 2
Boron Neutron Capture Therapy in Treating Patients With Melanoma
CompletedNCT00059800
Start: 2002-05-31End: 2004-01-31Updated: 2013-06-26
To Evaluate the Efficacy and Safety of Accelerator-Based Boron Neutron Capture Therapy (AB-BNCT) Combined With NBB-001 and NBB-002 for Patients With Recurrent Head and Neck Malignancies
RecruitingNCT07795034
Start: 2026-08-31End: 2028-12-01Target: 35Updated: 2026-09-08